Dashboard
1
With a growth in Net Profit of 22.4%, the company declared Very Positive results in Mar 25
- The company has declared positive results for the last 3 consecutive quarters
- RAW MATERIAL COST(Y) Fallen by -21.01% (YoY)
- PRE-TAX PROFIT(Q) At CNY 46.23 MM has Grown at 80.2%
- NET PROFIT(Q) At CNY 46.35 MM has Grown at 64.33%
2
With ROE of 4.29%, it has a fair valuation with a 1.06 Price to Book Value
3
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
65.9%
0%
65.9%
6 Months
65.27%
0%
65.27%
1 Year
71.15%
0%
71.15%
2 Years
51.22%
0%
51.22%
3 Years
50.7%
0%
50.7%
4 Years
61.77%
0%
61.77%
5 Years
35.74%
0%
35.74%
Tianshui Zhongxing Bio-Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.54%
EBIT Growth (5y)
5.40%
EBIT to Interest (avg)
1.94
Debt to EBITDA (avg)
2.02
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.32
Tax Ratio
0
Dividend Payout Ratio
91.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.85%
ROE (avg)
4.17%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
1.06
EV to EBIT
32.83
EV to EBITDA
11.59
EV to Capital Employed
1.05
EV to Sales
2.35
PEG Ratio
0.01
Dividend Yield
3.41%
ROCE (Latest)
3.19%
ROE (Latest)
4.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
471.90
517.50
-8.81%
Operating Profit (PBDIT) excl Other Income
47.70
104.50
-54.35%
Interest
11.80
20.30
-41.87%
Exceptional Items
1.90
10.20
-81.37%
Consolidate Net Profit
47.90
39.00
22.82%
Operating Profit Margin (Excl OI)
101.00%
59.90%
4.11%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is -8.81% vs 3.27% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is 22.82% vs -33.79% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,931.60
1,928.10
0.18%
Operating Profit (PBDIT) excl Other Income
414.00
449.20
-7.84%
Interest
77.10
84.20
-8.43%
Exceptional Items
15.30
-10.60
244.34%
Consolidate Net Profit
126.60
159.60
-20.68%
Operating Profit Margin (Excl OI)
65.90%
93.60%
-2.77%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 0.18% vs -2.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -20.68% vs 0.44% in Dec 2023
About Tianshui Zhongxing Bio-Technology Co., Ltd. 
Tianshui Zhongxing Bio-Technology Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






